Blueprint Medicines Reports First Quarter 2022 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. SPY
2. PCVX
3. NVDA
4. KLC
5. TSLA
6. PTC
7. CME
8. USO
9. AMD
10. EVTL

Go back to Blueprint Medicines Reports First Quarter 2022 Results

Blueprint Medicines (BPMC) Tops Q1 EPS by 11c

May 3, 2022 7:05 AM EDT

Blueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($1.79), $0.11 better than the analyst estimate of ($1.90). Revenue for the quarter came in at $62.73 million versus the consensus estimate of $38.96 million.

For earnings history and earnings-related data on Blueprint Medicines (BPMC) click here.

... More